• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2016
  • Select Year
    1. 2022
    2. 2021
    3. 2020
    4. 2019
    5. 2018
    6. 2017
    7. 2016
    8. 2015
    9. 2014
    10. 2013
    11. 2012
  • 23.12.2016

    【Tencent.com】天大藥業: 中期盈利大幅提升 雙輪驅動促發展(Chinese Version Only)

  • 28.11.2016

    【RoyalFlush】天大藥業中期淨利1150萬港元 同比增長313%(Chinese Version Only)

  • 28.11.2016

    【Tencent.com】天大藥業中期淨利1150萬港元 同比增長313%(Chinese Version Only)

  • 28.11.2016

    【Finet】天大藥業(00455-HK)中期賺1152萬增312%(Chinese Version Only)

  • 28.11.2016

    【AAstocks】TIANDA PHARMA (00455.HK) Interim Net Profit Surges 312.61%

  • 28.11.2016

    【ETNet】天大藥業(455)中期純利升3.1倍,現升逾12%(Chinese Version Only)

  • 28.11.2016

    【Eastmoney】天大藥業至9月底止6個月淨利同比增長312.6% (Chinese version only)

  • 28.11.2016

    【Hexun】快訊:市盈率高達154倍的天大藥業升11% (Chinese version only)

  • 28.11.2016

    【Sina】天大藥業中淨利1,150萬港元 同比增長313% (Chinese version only)

  • 28.11.2016

    【JRJ】天大藥業中期淨利1,150萬港元 同比增長313% (Chinese version only)

  • 14.09.2016

    【Tencent.com】香港智遠:天大藥業業務拓展迅猛 值得關注 (Chinese version only)

  • 14.09.2016

    【Sina】香港智遠:天大藥業業務拓展迅猛 值得關注 (Chinese version only)

  • 14.09.2016

    【JRJ】香港智遠:天大藥業業務拓展迅猛 值得關注 (Chinese version only)

  • 14.09.2016

    【RoyalFlush】香港智遠:天大藥業業務拓展迅猛 值得關注 (Chinese version only)

  • 17.08.2016

    【HKET】天大藥業投資之新加坡生物科技公司正進行胃癌、膽管癌等臨床試驗 (Chinese version only)

  • 17.08.2016

    【Tencent.com】天大藥業(00455):ASLAN相關腫瘤治療藥物研發方面進展順利 (Chinese version only)

  • 27.06.2016

    【Hexun】天大藥業賺660萬 扭虧轉盈 (Chinese version only)

  • 26.06.2016

    【Yahoo!Finance】《公司業績》天大藥業(00455.HK)年度扭虧賺657萬 末期息0.27仙 (Chinese version only)

  • 26.06.2016

    【AAstocks】《公司業績》天大藥業(00455.HK)年度扭虧賺657萬 末期息0.27仙 (Chinese version only)

  • 26.06.2016

    【Tencent.com】《公司业绩》天大药业(00455.HK)年度扭亏赚657万 末期息0.27仙 (Chinese version only)

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice